

High-Risk Beta
This platform is experimental. Smart contracts are unaudited. Use at your own risk.
Experts are trying to find the best way to screen for prostate cancer, since blood tests alone are not accurate enough for most men.
Tuesday, 2 June 2026
Connect your wallet to join the discussion.
No comments yet. Be the first to share your take.